BACKGROUND To explain why rates of colorectal cancer (CRC) screening including fecal occult blood testing (FOBT), flexible sigmoidoscopy (FS), colonoscopy (CS), and barium enema (BE), are low, this study assessed determinants of CRC screening from medical records. METHODS Data were abstracted from patients aged > or =64 years selected from each clinician from 30 diverse primary care practices...

nloaded kground: We aimed to define the potential of the fecal DNA assay as an alternative or in addition to rrently used immunochemical fecal occult blood test (iFOBT) for the early diagnosis of colorectal . thods: A total of 560 individuals aged 50 to 69 years with a positive iFOBT were recruited from an FOBT regional screening program. Twenty-six were diagnosed with adenocarcinoma, 264 with ...

Colorectal cancer represents the second most frequent neoplasia in mortality statistics of western countries. In Europe in 1996, there were 213111 cases and 110669 deaths from colorectal cancer (Table 1) [1]. The trend in incidence from 1970 projected to 2006 (R. Capocaccia and A. Verdecchia, personal communication) shows a steady increase in all European countries, whereas in the USA there has...

Valid and reliable self-report measures of cancer screening behaviors are important for evaluating efforts to improve adherence to guidelines. We evaluated test-retest reliability and validity of self-report of the fecal occult blood test (FOBT), sigmoidoscopy (SIG), colonoscopy (COL), and barium enema (BE) using the National Cancer Institute colorectal cancer screening (CRCS) questionnaire. A ...

Aims: Endoscopic evaluation of symptomless IDA patients and related lesions.
 Study Design: A Cross-sectional epidemiological study.
 Place Duration Study: The hematology unit the Internal medicine department in Tanta university hospital, duration study was 6 months from 1 January to 31 June 2019.
 Methodology: 100 consecutive with laboratory base diagnosis without GI symptoms we...

Background & AimsRandomized trials have shown that biennial fecal occult blood test (FOBT) screening reduces mortality from colorectal cancer (CRC), but not overall mortality. Differences in benefit for men vs women, and by age, are unknown. We sought to evaluate long-term reduction all-cause CRC-specific women who comply with offered screening, different age groups, using individual participan...

Screening methods and programs are critical strategies for the early detection and timely treatment of some cancers. Established methods for early detection of cancer include mammography, clinical breast examination (CBE), the Papanicolaou (Pap) test, proctosigmoidoscopy, fecal occult blood test (FOBT), and digital rectal examination (DRE) (1-4). To examine changes in the reported use of select...

Clinical trials conducted in the Nottingham (UK), Funen (Denmark) and Minnesota (USA) using faecal occult blood testing (FOBT) showed evidence that population-based screening with FOBT could reduce mortality from colorectal cancer (CRC) [1–3]. At first glance, these results could be interpreted as positive signals for implementing large-scale screening programmes using FOBT. Faecal occult blood...

BACKGROUND Although colorectal cancer screening by using a fecal occult blood test (FOBT), flexible sigmoidoscopy, colonoscopy, or barium enema x-ray reduces the incidence of and death from colorectal cancer, the rate of colorectal cancer screening in the general population is low. We conducted a randomized trial consisting of direct mailing of FOBT kits to increase colorectal cancer screening ...

The article by Choi et al in this issue of Seminars in Oncology [1] is an excellent review of the different modalities available for colorectal cancer screening. While one often hears that the best screening test is the one that the patient will accept (and there is truth to this axiom), for the most part one can infer from the paper by Choi et al that barium enemas and computed tomography (CT)...